学习这个临床的用意：Phase II Anti-PD1 Epigenetic Priming Study in NSCLC: 🔗 网页链接 ; 读读这篇文章的思路：Expression of PD-L1, PD-L2, PD-1 & CTLA4 in MDS is enhanced by treatment with hypomethylating agents: 🔗 网页链接 (Leukemia, 20 Dec 2013)展开全文 原微博
SHIVA trial, 1st randomized trial of targeted cancer medicine in all tumor types. ECC2013 (European Cancer Congress), September 27, Amsterdam, The Netherlands //@动感超人2013: 转发微博展开全文 原微博
赞樱花，还是俳句有意境。刚写了三首5，7，5，意思大致相近，却觉得中文表达出任性恣意的青春，日文折中温和，英文平静却蕴藏着力量--- 我盛开着等 与风共舞的一瞬 恣意地飞扬// 桜咲く 風に舞い飛ぶ 花吹雪// perfect in pale pink/ waiting on that right moment/ to go with the wind展开全文
Tecfidera is highly anticipated with forcasted sales of $250 million this year, $1.8 billion in 2015 and $2.7B in 2017. Biogen is seeking FDA approval for Plegridy. It has another ms candidate, daclizumab, in development with AbbV. 🔗 网页链接 🔗 网页链接展开全文 原微博
